José Luis Fuster Soler

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Martinez Banaclocha H, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide early interventions in childhood acute lymphoblastic leukemia. Clin Transl Oncol. 2023 Jun 27. doi: 10.1007/s12094-023-03251-0. Online ahead of print. PubMed PMID: 37368200.

AÑO: 2023; IF: 3.4

37368200

Moreno C, Ramos-Elbal E, Velasco P, Aguilar Y, Gonzaalez Martinez B, Fuentes C, Molinos A, Guerra-Garcia P, Palomo P, Verdu J, Adan Pedroso RM, Vagace JM, Lopez-Duarte M, Regueiro A, Tasso M, Dapena JL, Salinas JA, Navarro S, Bautista F, Lassaletta A, Lendinez F, Rives S, Pascual A, Rodriguez A, Perez-Hurtado JM, Fernandez JM, Perez-Martinez A, Gonzalez-Vicent M, Diaz de Heredia C, Fuster JL. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet). Front Pediatr. 2023 Mar 20;11:1140637. doi: 10.3389/fped.2023.1140637. eCollection 2023. PubMed PMID: 37020654; PubMed Central PMCID: PMC10067875.

AÑO: 2023; IF: 2.6

37020654

Ramos Elbal E, Fuster JL, Campillo JA, Galera AM, Cortes MB, Llinares ME, Jimenez I, Plaza M, Banaclocha HM, Galian JA, Blanquer Blanquer M, Martinez Sanchez MV, Muro M, Minguela A. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia. Clin Transl Oncol. 2023 Jan 4. doi: 10.1007/s12094-022-03042-z. Online ahead of print. PubMed PMID: 36598635.

AÑO: 2023; IF: 3.4

36598635

Ramos-Muntada M, Trincado JL, Blanco J, Bueno C, Rodriguez-Cortez VC, Bataller A, Lopez-Millan B, Schwab C, Ortega M, Velasco P, Blanco ML, Nomdedeu J, Ramirez-Orellana M, Minguela A, Fuster JL, Cuatrecasas E, Camos M, Ballerini P, Escherich G, Boer J, DenBoer M, Hernandez-Rivas JM, Calasanz MJ, Cazzaniga G, Harrison CJ, Menendez P, Molina O. Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia. Mol Oncol. 2022 Aug;16(16):2899-2919. doi: 10.1002/1878-0261.13276. Epub 2022 Jul 19. PubMed PMID: 35726693; PubMed Central PMCID: PMC9394234.

AÑO: 2022; IF: 6.6

35726693

Ferrandez-Pujante A, Perez-Silva A, Serna-Munoz C, Fuster-Soler JL, Galera-Minarro AM, Cabello I, Ortiz-Ruiz AJ. Prevention and Treatment of Oral Complications in Hematologic Childhood Cancer Patients: An Update. Children (Basel). 2022 Apr 15;9(4):566. doi: 10.3390/children9040566. PubMed PMID: 35455610; PubMed Central PMCID: PMC9029683.

AÑO: 2022; IF: 2.835

35455610